PRESCRIBING HABITS OF VANCOMYCIN IN THE EMERGENCY DEPARTMENT: ARE WE DOSING APPROPRIATELY?

被引:11
作者
Rosini, Jamie M. [1 ]
Grovola, Michael R. [2 ]
Levine, Brian J. [2 ]
Jasani, Neil B. [2 ]
机构
[1] Christiana Care Hlth Syst, Dept Pharm, Newark, DE USA
[2] Christiana Care Hlth Syst, Dept Emergency Med, Newark, DE USA
关键词
vancomycin; weight-based; Emergency Medicine; dosing; MRSA; RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-TREATMENT; OUTCOMES; GUIDELINES;
D O I
10.1016/j.jemermed.2012.11.051
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: To prevent the development of bacterial resistance, current guidelines recommend vancomycin dosages of 15-20 mg/kg based on actual body weight. Objective: Our aim was to determine if two community teaching Emergency Departments followed the new recommendations for a weight-based dosing regimen for vancomycin. Methods: A retrospective cohort study was conducted on the prescribing habits of vancomycin in the Emergency Department. During a 6-month time period, 1,734 doses of vancomycin were dispensed and a subsequent random sample of 240 doses was reviewed. Data collection included age, gender, weight, creatinine clearance, vancomycin dose, and indication for vancomycin therapy. Mean values, standard deviations, and ranges were computed to illustrate current prescribing practices. Results: The mean vancomycin dose was 1,117 +/- 325 mg. Based on actual body weight, the calculated mean dose was 14.6 +/- 5.7 mg/kg. Only 19.6% (47 of 240) of all patients received an appropriate dose based on the recommended 15-20 mg/kg vancomycin dose. Conclusions: Our Emergency Department is inappropriately dosing vancomycin in the majority of patients. Educating clinicians regarding appropriate vancomycin dosing is recommended to achieve compliance with the latest consensus guidelines. (C) 2013 Elsevier Inc.
引用
收藏
页码:979 / 984
页数:6
相关论文
共 14 条
[1]   Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid [J].
Craig, WA .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2003, 17 (03) :479-+
[2]   The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting [J].
Ibrahim, EH ;
Sherman, G ;
Ward, S ;
Fraser, VJ ;
Kollef, MH .
CHEST, 2000, 118 (01) :146-155
[3]   Effects of Targeting Higher Vancomycin Trough Levels on Clinical Outcomes and Costs in a Matched Patient Cohort [J].
Kullar, Ravina ;
Davis, Susan L. ;
Taylor, Thomas N. ;
Kaye, Keith S. ;
Rybak, Michael J. .
PHARMACOTHERAPY, 2012, 32 (03) :195-201
[4]   Impact of Vancomycin Exposure on Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets [J].
Kullar, Ravina ;
Davis, Susan L. ;
Levine, Donald P. ;
Rybak, Michael J. .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (08) :975-981
[5]   Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock [J].
Kumar, Arland ;
Roberts, Daniel ;
Wood, Kenneth E. ;
Light, Bruce ;
Parrillo, Joseph E. ;
Sharma, Satendra ;
Suppes, Robert ;
Feinstein, Daniel ;
Zanotti, Sergio ;
Taiberg, Leo ;
Gurka, David ;
Kumar, Aseem ;
Cheang, Mary .
CRITICAL CARE MEDICINE, 2006, 34 (06) :1589-1596
[6]  
Leibovici L, 1998, J INTERN MED, V244, P379
[7]  
Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI [10.1093/cid/cir034, 10.1093/cid/ciq146]
[8]   Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia [J].
Lodise, TP ;
McKinnon, PS ;
Swiderski, L ;
Rybak, MJ .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (11) :1418-1423
[9]  
Moise PA, 2000, INT J ANTIMICROB AG, V16, pS31, DOI 10.1016/S0924-8579(00)00303-4
[10]   Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy [J].
Moise-Broder, PA ;
Sakoulas, G ;
Eliopoulos, GM ;
Schentag, JJ ;
Forrest, A ;
Moellering, RC .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) :1700-1705